Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifeway Foods (LWAY) EBITDA (2016 - 2025)

Historic EBITDA for Lifeway Foods (LWAY) over the last 15 years, with Q3 2025 value amounting to $6.0 million.

  • Lifeway Foods' EBITDA rose 2128.74% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.4 million, marking a year-over-year decrease of 2406.78%. This contributed to the annual value of $16.7 million for FY2024, which is 1488.0% down from last year.
  • Per Lifeway Foods' latest filing, its EBITDA stood at $6.0 million for Q3 2025, which was up 2128.74% from $6.6 million recorded in Q2 2025.
  • Over the past 5 years, Lifeway Foods' EBITDA peaked at $6.6 million during Q2 2025, and registered a low of -$393000.0 during Q1 2022.
  • Over the past 5 years, Lifeway Foods' median EBITDA value was $2.8 million (recorded in 2021), while the average stood at $3.4 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 11428.57% in 2022, then skyrocketed by 63053.44% in 2023.
  • Over the past 5 years, Lifeway Foods' EBITDA (Quarter) stood at $1.1 million in 2021, then skyrocketed by 142.06% to $2.6 million in 2022, then surged by 150.76% to $6.4 million in 2023, then tumbled by 77.0% to $1.5 million in 2024, then surged by 303.11% to $6.0 million in 2025.
  • Its EBITDA was $6.0 million in Q3 2025, compared to $6.6 million in Q2 2025 and $2.4 million in Q1 2025.